Lifecore Biomedical Inc
LFCR7.930USD
+0.230+2.99%
收盤 09/18, 16:00（美東）報價延遲15分鐘
293.62M總市值
虧損本益比TTM
關於 Lifecore Biomedical Inc 公司
Lifecore Biomedical, Inc. 是一家完全一體化的合同開發和製造組織 (CDMO)。該公司爲生物材料市場設計、開發、製造和銷售差異化產品，並向合作伙伴授權技術應用。該公司在注射器和小瓶中無菌注射級藥品的開發、灌裝和完成方面提供高度差異化的能力。該公司參與制造散裝藥用級透明質酸鈉 (HA)，以及用於治療一系列醫療狀況和程序的注射產品的配製和灌裝注射器和小瓶。該公司利用其發酵工藝和無菌配方和灌裝專業知識來開發用於多種應用的基於 HA 的產品，並利用非 HA 設備和藥物機會。
公司簡介
公司代碼LFCR
公司名稱Lifecore Biomedical Inc
上市日期Feb 15, 1996
CEOMr. Paul Josephs
員工數量406
證券類型Ordinary Share
年結日Feb 15
公司地址3515 Lyman Boulevard
城市CHASKA
上市交易所NASDAQ Global Select Consolidated
國家United States of America
郵編55318
電話19523684300
網址https://www.lifecore.com/
公司代碼LFCR
上市日期Feb 15, 1996
CEOMr. Paul Josephs
公司高階主管
名稱
名稱/職務
職務
持股
持股變動
Mr. Thomas (Tom) Salus
Mr. Thomas (Tom) Salus
Chief Legal and Administrative Officer , Corporate Secretary
Chief Legal and Administrative Officer , Corporate Secretary
240.98K
+12.08%
Mr. Paul Josephs
Mr. Paul Josephs
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
133.33K
+249.16%
Mr. Joshua E. Schechter
Mr. Joshua E. Schechter
Independent Director
Independent Director
79.17K
+32.69%
Mr. Ryan David Lake
Mr. Ryan David Lake
Chief Financial Officer, Executive Vice President, Company Secretary
Chief Financial Officer, Executive Vice President, Company Secretary
74.19K
-23.61%
Mr. Jason M. Aryeh
Mr. Jason M. Aryeh
Independent Director
Independent Director
44.06K
+79.44%
Mr. Nelson Obus
Mr. Nelson Obus
Independent Director
Independent Director
19.51K
--
Ms. Jackie Klecker
Ms. Jackie Klecker
Executive Vice President - Quality and Development Services
Executive Vice President - Quality and Development Services
--
--
Mr. Christopher Kiper
Mr. Christopher Kiper
Independent Director
Independent Director
--
--
Mr. Humberto C. Antunes, M.D.
Mr. Humberto C. Antunes, M.D.
Independent Director
Independent Director
--
--
Ms. Stephanie Diaz
Ms. Stephanie Diaz
IR Contact Officer
IR Contact Officer
--
--
查看更多
名稱
名稱/職務
職務
持股
持股變動
Mr. Thomas (Tom) Salus
Mr. Thomas (Tom) Salus
Chief Legal and Administrative Officer , Corporate Secretary
Chief Legal and Administrative Officer , Corporate Secretary
240.98K
+12.08%
Mr. Paul Josephs
Mr. Paul Josephs
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
133.33K
+249.16%
Mr. Joshua E. Schechter
Mr. Joshua E. Schechter
Independent Director
Independent Director
79.17K
+32.69%
Mr. Ryan David Lake
Mr. Ryan David Lake
Chief Financial Officer, Executive Vice President, Company Secretary
Chief Financial Officer, Executive Vice President, Company Secretary
74.19K
-23.61%
Mr. Jason M. Aryeh
Mr. Jason M. Aryeh
Independent Director
Independent Director
44.06K
+79.44%
Mr. Nelson Obus
Mr. Nelson Obus
Independent Director
Independent Director
19.51K
--
收入明細
單位: USD更新時間: 3月4日 週二
單位: USD更新時間: 3月4日 週二
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2021
FY2020
FY2019
業務USD
名稱
營收
佔比
Contract development and manufacturing organization ("CDMO")
17.81M
64.53%
Fermentation
8.52M
30.87%
Olive oil and wine vinegars
1.27M
4.60%
Technology
0.00
0.00%
地區USD
名稱
營收
佔比
United States
16.40M
59.42%
Switzerland
6.80M
24.64%
Ireland
1.10M
3.99%
Australia
1.10M
3.99%
Canada
700.00K
2.54%
其他
1.50M
5.43%
業務
地區
業務USD
名稱
營收
佔比
Contract development and manufacturing organization ("CDMO")
17.81M
64.53%
Fermentation
8.52M
30.87%
Olive oil and wine vinegars
1.27M
4.60%
Technology
0.00
0.00%
股東統計
更新時間: 8月19日 週二
更新時間: 8月19日 週二
持股股東
股東類型
持股股東
持股股東
佔比
Wynnefield Capital, Inc.
12.70%
Legion Partners Asset Management, LLC
11.97%
Greenhaven Road Investment Management, L.P.
9.98%
325 Capital LLC
5.84%
Laughing Water Capital, LP
5.13%
其他
54.38%
持股股東
持股股東
佔比
Wynnefield Capital, Inc.
12.70%
Legion Partners Asset Management, LLC
11.97%
Greenhaven Road Investment Management, L.P.
9.98%
325 Capital LLC
5.84%
Laughing Water Capital, LP
5.13%
其他
54.38%
股東類型
持股股東
佔比
Hedge Fund
30.83%
Investment Advisor
24.98%
Investment Advisor/Hedge Fund
18.56%
Individual Investor
1.99%
Research Firm
1.84%
Bank and Trust
0.12%
Private Equity
0.08%
Venture Capital
0.05%
Insurance Company
0.02%
其他
21.53%
機構持股
更新時間: 7月1日 週二
更新時間: 7月1日 週二
報告期間
機構數
持股數
持股佔比
持股變動
2025Q2
212
27.35M
73.90%
-2.82M
2025Q1
229
29.94M
81.56%
-2.38M
2024Q4
243
30.30M
82.90%
-2.02M
2024Q3
234
26.35M
84.61%
-494.37K
2024Q2
224
23.91M
77.61%
-4.44M
2024Q1
225
24.56M
80.40%
-3.68M
2023Q4
221
23.64M
77.94%
-3.68M
2023Q3
229
20.71M
68.28%
-6.48M
2023Q2
237
20.72M
68.32%
-8.44M
2023Q1
244
23.24M
76.67%
-6.53M
查看更多
股東持股明細
名稱
持股數
佔比
持股變動
變動比例
公告日期
Wynnefield Capital, Inc.
4.70M
12.7%
--
--
Mar 31, 2025
Legion Partners Asset Management, LLC
4.43M
11.97%
--
--
Mar 31, 2025
Greenhaven Road Investment Management, L.P.
3.62M
9.77%
--
--
Mar 31, 2025
325 Capital LLC
2.16M
5.84%
+1.37M
+172.80%
Mar 31, 2025
Laughing Water Capital, LP
1.90M
5.13%
+321.80K
+20.39%
Feb 18, 2025
David Capital Partners, LLC
1.80M
4.87%
+148.00K
+8.94%
Dec 31, 2024
BlackRock Institutional Trust Company, N.A.
1.63M
4.41%
+134.35K
+8.97%
Mar 31, 2025
The Vanguard Group, Inc.
1.55M
4.18%
+15.96K
+1.04%
Mar 31, 2025
Geode Capital Management, L.L.C.
750.50K
2.03%
+64.75K
+9.44%
Mar 31, 2025
查看更多
持股ETF
機構名稱
佔比
暫無數據
分紅派息
近5年累計派現
0.00
美元
公告日期
分紅計劃
股權登記日
現金發放日
除權除息日
暫無數據
拆合股
公告日期
類型
比率
暫無數據
公告日期
類型
比率
暫無數據
